Oral and intranasal immunization with food-grade recombinant Lactococcus lactis expressing high conserved region of SARS-CoV-2 spike protein triggers mice’s immunity responses-Reference-Cited by-同舟云学术

Oral and intranasal immunization with food-grade recombinant Lactococcus lactis expressing high conserved region of SARS-CoV-2 spike protein triggers mice’s immunity responses

Published:2023-04 Issue: Volume:13 Page:100265
ISSN:2590-1362
Container-title:Vaccine: X
language:en
Short-container-title:Vaccine: X

Author:

Yurina Valentina^ORCID,Rahayu Adianingsih Oktavia,Widodo Nashi

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference39 articles.

1. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak;Rothan;J Autoimmun [Internet] Elsevier,2020

2. Epidemiologic clues to SARS origin in China;Xu;Emerg Infect Dis,2004

3. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review;Chen;J Infect Dis,2022

4. Coronavirus disease 2019 (COVID-19): A literature review;Harapan;J Infect Public Health [Internet],2020

5. Symptoms, complications and management of long COVID: a review;Aiyegbusi;J R Soc Med,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral administration of recombinant Lactococcus lactis expressing largemouth bass (Micropterus salmoides) IFNa3 protein enhances immune response against largemouth bass virus (LMBV) infection;Fish & Shellfish Immunology;2024-11

2. Targeted Bioimaging of Microencapsulated Recombinant LAB Vector Expressing Fluorescent Reporter Protein: A Non-invasive Approach for Microbial Tracking;ACS Biomaterials Science & Engineering;2024-08-01

3. Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19;Microbial Cell Factories;2024-02-06

4. Mucosal vaccination: onward and upward;Expert Review of Vaccines;2023-10-17

5. Mucosal immune probiotic vector vaccines: Development and prospects for application in COVID-19;One Health Bulletin;2023-10